Not yet recruitingInterventionalPhase 2Last updated Aug 7, 2026

Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma

Efficacy and Safety of Penpulimab Combined With Chemotherapy as Neoadjuvant Therapy in Patients With Locally Advanced Hypopharyngeal Carcinoma

Overview

ClinicalTrials.gov ID: NCT07752394
Lead Sponsor: Tang-Du HospitalOTHER
Brief Summary: This is a prospective, single-arm, phase II clinical study aimed to evaluate the efficacy and safety of penpulimab combined with chemotherapy in the treatment of locally advanced hypopharyngeal carcinoma.
Study Type: Interventional

Status

Study Record Dates

NCT07248956Recruiting

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

NCT06081673Recruiting

Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC

NCT07538206Not yet recruiting

Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma

NCT07137039Not yet recruiting

Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen

NCT04156698Unknown status

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

NCT06151743Recruiting

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma